Cargando…

Stability-indicating HPLC–DAD methods for determination of two binary mixtures: Rabeprazole sodium–mosapride citrate and rabeprazole sodium–itopride hydrochloride

Two selective stability-indicating HPLC methods are described for determination of rabeprazole sodium (RZ)–mosapride citrate (MR) and RZ–itopride hydrochloride (IO) mixtures in the presence of their ICH-stress formed degradation products. Separations were achieved on X-Bridge C18 column using two mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Fatatry, Hamed M., Mabrouk, Mokhtar M., Hewala, Ismail I., Emam, Ehab H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Xi'an Jiaotong University 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761220/ https://www.ncbi.nlm.nih.gov/pubmed/29403889 http://dx.doi.org/10.1016/j.jpha.2013.09.009

Ejemplares similares

Quantitative Estimation of Itopride Hydrochloride and Rabeprazole Sodium from Capsule Formulation
por: Pillai, S., et al.
Publicado: (2008)

Simultaneous HPTLC Determination of Rabeprazole and Itopride Hydrochloride From Their Combined Dosage Form
por: Suganthi, A., et al.
Publicado: (2008)

Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone
por: Iida, Hiroshi, et al.
Publicado: (2017)

A multicenter randomized trial comparing rabeprazole and itopride in patients with functional dyspepsia in Japan: the NAGOYA study
por: Kamiya, Takeshi, et al.
Publicado: (2017)

Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography
por: Perumal, Senthamil Selvan, et al.
Publicado: (2014)

Gastrointestinal bleed induced by a fixed dose combination of rabeprazole and diclofenac sodium
por: Tandon, Vishal R., et al.
Publicado: (2014)

Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole
por: Bae, Sungyeun, et al.
Publicado: (2023)

Validation and Application of a New Reversed Phase HPLC Method for In Vitro Dissolution Studies of Rabeprazole Sodium in Delayed-Release Tablets
por: Nawaz, Md. Saddam
Publicado: (2013)

Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance
por: Tirpude, Rakesh N., et al.
Publicado: (2011)

Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules
por: Tan, Yinhe, et al.
Publicado: (2016)

Quality by Design Applied Development of Immediate-Release Rabeprazole Sodium Dry-Coated Tablet
por: Lee, Sang-Ho, et al.
Publicado: (2021)

Spectrophotometric methods for simultaneous estimation of rabeprazole sodium and aceclofenac from the combined capsule dosage form
por: Sawant, Ramesh L., et al.
Publicado: (2011)

Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation
por: Kumar, Navneet, et al.
Publicado: (2013)

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori
por: Chen, Xing Xing, et al.
Publicado: (2022)

In Vitro Effects of Rabeprazole on Human Pylorus Tone
por: Yaşar, Necdet Fatih, et al.
Publicado: (2015)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
por: Ochoa, Dolores, et al.
Publicado: (2020)

A review of rabeprazole in the treatment of acid-related diseases
por: Pace, Fabio, et al.
Publicado: (2007)

Effect of rabeprazole on the transport and distribution of levofloxacin in rat stomachs
por: BAO, JUNJUN, et al.
Publicado: (2014)

Multiple widespread fixed drug eruption caused by rabeprazole
por: Gupta, S, et al.
Publicado: (2020)

Impact of Rabeprazole on APO-Dabigatran Exposure in Healthy Volunteers
por: Chan, Noel, et al.
Publicado: (2022)

Ten mg dexrabeprazole daily is as effective as 20 mg rabeprazole daily
por: Kanakia, Rajendra, et al.
Publicado: (2008)

Rabeprazole exhibits antiproliferative effects on human gastric cancer cell lines
por: GU, MENGLI, et al.
Publicado: (2014)

Rabeprazole inhibits inflammatory reaction by inhibition of cell pyroptosis in gastric epithelial cells
por: Xie, Jing, et al.
Publicado: (2021)

Repurposing of rabeprazole as an anti-Trypanosoma cruzi drug that targets cellular triosephosphate isomerase
por: García-Torres, Itzhel, et al.
Publicado: (2023)

The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease
por: Chen, Ying, et al.
Publicado: (2013)

Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique
por: Khan, Ruqaiyah, et al.
Publicado: (2014)

Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic–Pharmacodynamic Modeling
por: Jeong, Seung-Hyun, et al.
Publicado: (2023)

Stability indicating high performance thin-layer chromatographic method for simultaneous estimation of pantoprazole sodium and itopride hydrochloride in combined dosage form
por: Bageshwar, Deepak, et al.
Publicado: (2011)

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial
por: Tai, Wei-Chen, et al.
Publicado: (2023)

Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux
por: Shin, Myung-Hee, et al.
Publicado: (2012)

A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form
por: Raval, P. B., et al.
Publicado: (2008)

Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Effect of Itopride Hydrochloride on the Ileal and Colonic Motility in Guinea Pig In Vitro
por: Lim, Hyun Chul, et al.
Publicado: (2008)

Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers
por: Kim, Hyung-Keun, et al.
Publicado: (2012)

Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules
por: Thummala, Veera Raghava Raju, et al.
Publicado: (2014)

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
por: Wu, Meng-Chieh, et al.
Publicado: (2017)

Endoscopic Evaluation of Gastric Emptying and Effect of Mosapride Citrate on Gastric Emptying
por: Jung, In Su, et al.
Publicado: (2010)

Effects of the Oral Administration of Mosapride Citrate on Capsule Endoscopy Completion Rate
por: Ida, Yosuke, et al.
Publicado: (2012)

Determination of Montelukast Sodium and Bambuterol Hydrochloride in Tablets using RP HPLC
por: Patil, Smita, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_m1se0l5igkrotb3i9v34t160c7